The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblastic lymphadenopathy with dysproteinemia
Open Access
- 1 January 1999
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 104 (1) , 163-165
- https://doi.org/10.1046/j.1365-2141.1999.01139.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Angioimmunoblastic Lymphadenopathy with Dysproteinemia: Emphasis on Pathogenesis and TreatmentActa Haematologica, 1998
- Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosineAnnals of Hematology, 1996
- 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T- cell lymphomaBlood, 1992
- Angioimmunoblastic Lymphadenopathy with DysproteinemiaAnnals of Internal Medicine, 1988
- Angio-immunoblastic lymphadenopathyThe American Journal of Medicine, 1975
- Immunoblastic LymphadenopathyNew England Journal of Medicine, 1975